Clinical trial
Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy
NCT00999804
Study timeline
Study start (actual)2011-10-01Date precision: month
Registry last updated2025-03-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
LapatinibDRUG · verified · RxNorm: lapatinib
LetrozoleDRUG · verified · RxNorm: letrozole
TrastuzumabDRUG · verified · RxNorm: trastuzumab
Sponsors & collaborators
Baylor Breast Care Centerlead sponsor
Translational Breast Cancer Research Consortiumcollaborator
GlaxoSmithKlinecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00999804 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.